Company
United StatesPublic company, NASDAQ: LINLinde Inc (NASDAQ: LIN), Lugoff, SC – FDA Inspections
Inspection records and compliance data for Linde Inc in Lugoff, South Carolina. 1 FDA inspection on record, last inspected August 18, 2014. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc based in Lugoff, South Carolina, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected August 18, 2014.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 18, 2014 | NAI | Human Drugs · Drug Quality Assurance | 898005 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
3004341093
Address
Linde Ln, Hwy 12, Lugoff, South Carolina 29078, United States
Country
United States
ID: b2de25ab-b998-4ecc-ae2a-02461abe09bb